Publications
34
Citations
1,012
Est. group size
—
Recurring co-author estimate
Active years
30
Publishing since 1995
Amy Bartlett's research spans two areas: genetic and molecular studies of neuromuscular and neurodegenerative conditions (such as inclusion body myositis and related muscle/nerve disorders), and applied diagnostic testing methods, including mass-spectrometry-based tests for SARS-CoV-2. This suggests work that connects genetic disease research with clinical laboratory test development. Prospective students might expect exposure to both molecular genetics research and translational diagnostic technology development.
Publication output has been modest and somewhat variable over the last decade, with a peak around 2018-2021 and a slowing trend in the most recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Operation Moonshot: rapid translation of a SARS-CoV-2 targeted peptide immunoaffinity liquid chromatography-tandem mass spectrometry test from research into routine clinical use
Clinical Chemistry and Laboratory Medicine (CCLM) · 2022
- Rapid and Sensitive Detection of SARS-CoV-2 Infection Using Quantitative Peptide Enrichment LC-MS Analysis
medRxiv · 2021
- Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis
Neurobiology of Aging · 2016
- Neurology×7
- Annals of Clinical and Translational Neurology×3
- Muscle & Nerve×2
- Frontiers in Neurology×2
- JAMA Neurology×2
- W. David Arnold
Medicine · The Ohio State University
- Kelly Rich
Medicine · The Ohio State University
- Marcia V. Felker
Medicine · Indiana University
- Sarah Heintzman
Medicine · The Ohio State University
- Stephen J. Kolb
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile